Citation 1: Liu Z, Deng M, Xiang J, et al. A novel spider peptide toxin suppresses tumor growth through dual signaling pathways. Curr Mol Med. 2012;12(10):1350-60. Published 2012 Dec. doi:10.2174/156652412803833643
Citation 2: Tan H, Ding X, Meng S, et al. Antimicrobial potential of lycosin-I, a cationic and amphiphilic peptide from the venom of the spider Lycosa singorensis. Curr Mol Med. 2013;13(6):900-10. Published 2013 Jul. doi:10.2174/15665240113139990045
Citation 3: Wang L, Wang YJ, Liu YY, et al. In vitro potential of Lycosin-I as an alternative antimicrobial drug for treatment of multidrug-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2014;58(11):6999-7002. Published 2014 Nov. doi:10.1128/AAC.03279-14
Citation 4: Tan H, Luo W, Wei L, et al. Quantifying the Distribution of the Stoichiometric Composition of Anticancer Peptide Lycosin-I on the Lipid Membrane with Single Molecule Spectroscopy. J Phys Chem B. 2016;120(12):3081-8. Published 2016 Mar 31. doi:10.1021/acs.jpcb.5b12618
Citation 5: Tan H, Huang Y, Xu J, et al. Spider Toxin Peptide Lycosin-I Functionalized Gold Nanoparticles for in vivo Tumor Targeting and Therapy. Theranostics. 2017;7(12):3168-3178. Published 2017. doi:10.7150/thno.19780
Citation 6: Tan L, Bai L, Wang L, et al. Antifungal activity of spider venom-derived peptide lycosin-I against Candida tropicalis. Microbiol Res. 2018;216:120-128. Published 2018 Nov. doi:10.1016/j.micres.2018.08.012
Citation 7: Ma B, Xi Z, Li J, et al. Vasodilator and hypotensive effects of the spider peptide Lycosin-I in vitro and in vivo. Peptides. 2018;99:108-114. Published 2018 Jan. doi:10.1016/j.peptides.2017.12.011
Citation 8: Tang Y, Hou S, Li X, et al. Anti-parasitic effect on Toxoplasma gondii induced by a spider peptide lycosin-I. Exp Parasitol. 2019;198:17-25. Published 2019 Mar. doi:10.1016/j.exppara.2019.01.009